ArticleNaunyn-Schmiedeberg's archives of pharmacology2023

Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells.

Gamze Guney Eskiler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.